We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Minimally Invasive Cancer Diagnostic Device Eavesdrops On Cells’ Conversations

By LabMedica International staff writers
Posted on 26 Oct 2023
Print article
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)

For a long time, scientists have understood that RNA (ribonucleic acid) serves as an internal messenger within cells, taking DNA's instructions to help the cells produce proteins. However, a recent discovery shows that specific kinds of RNA, termed "extracellular RNA" or exRNA, actually leave the cell. These exRNAs are enclosed in tiny carrier structures and travel through bodily fluids, acting like tiny informational messages in bottles. These exRNAs are incredibly valuable as they could hold early indicators for diseases like cancer, heart disease, and HIV. Detecting diseases via exRNA could be quicker, more effective, and cheaper than current techniques. The challenge, however, has been separating and interpreting these exRNAs, as existing methods like advanced filters and centrifuges haven't been very successful.

A team of scientists at the University of Notre Dame (Notre Dame, IN, USA) has created a groundbreaking device that uses an ingenious approach to 'eavesdrop' on cells’ conversations. This palm-sized device combines existing technologies and employs a mix of pH levels and electrical charges to segregate the exRNA carriers. The unique feature here is that each type of carrier has its own "isoelectric point," a particular pH level at which it has no positive or negative charge. Within the device, there's a seemingly simple stream of water flowing. But this stream is special. On the left side, the water is highly acidic, similar to grapefruit juice. On the opposite end of the stream, the water is extremely basic, with a pH similar to a bottle of ammonia. What's particularly remarkable about the device is its ability to generate this pH gradient in the stream without adding any chemicals, making it cost-effective and eco-friendly.

This gradient is made possible by a two-sided membrane that's powered by a custom-designed chip. This membrane divides the water into two types of ions: acidic hydronium ions and basic hydroxide ions, adding a different kind of ion to each side of the stream. As these acidic and basic streams converge, they form a pH gradient, much like how hot and cold streams form hot and cold sides with a gradient of temperature through the middle of the stream. The researchers ran the two devices in parallel and utilized machine learning to select the ideal pH range needed for separating the carriers.

What sets this approach apart is its effectiveness of the pH gradient in segregating the exRNA carriers floating in the stream. When they pass through the pH gradient, the different types of carriers form lines along their isoelectric points, making it easy to channel them into separate outlets. The researchers could obtain incredibly pure samples—up to 97%—using less than a milliliter of body fluids like blood plasma, saliva, or urine. Moreover, while the best current technologies take around a day to separate samples, this new device accomplished the task in just 30 minutes.

“Noncommunicable diseases are responsible for more than 70 percent of deaths worldwide, and cardiovascular disease and cancer are responsible for most of that number,” said postdoctoral fellow Himani Sharma who served as project lead. “Our technology shows a path to improving the way clinicians diagnose these diseases, and that could save a tremendous number of lives.”

Related Links:
University of Notre Dame

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.